Clinical and Post-Market
Demonstrate complete regulatory compliance by ensuring your in vitro diagnostic (IVD) device conforms to all applicable global requirements.
Delivering compliant IVD products to global markets
Choose Apotech for clinical compliance you can trust
Before placing an IVD device on the market, manufacturers must demonstrate compliance with all applicable global regulatory requirements including In Vitro Diagnostic Regulation (IVDR), 21 CFR and the UK MDR 2002.
At Apotech, our experienced team can make sure that you are conforming with the appropriate conformity assessment procedures. Working on your behalf, we can help you demonstrate that your IVD device achieves its intended purpose and corresponds to its claimed performance throughout its lifetime.
Trusted by top-tier teams worldwide
Why choose Apotech for IVD clinical and post-market services?
Article 56 (1) of the IVDR states that IVD manufacturers must specify and justify the level of clinical evidence given a device’s characteristics and its intended purpose. Therefore, defining this intended purpose must be considered a key driver behind its overall assessment.
Manufacturers must also ensure that they meet the essential requirements of the Medical Devices Regulations 2002 using data gathered through a performance evaluation.
At Apotech, we can support you during the clinical stages of your IVD development in the following areas:
FAQs on IVD clinical and post-market services
At Apotech, we provide a tailored approach to our IVD clinical and post-market services. We aim to make the process as simple to understand as possible and are always on hand to answer any questions you might have.
Here are some of the questions we get asked most often.
Featured case studies
GCP Audits – Europe
Seagen is a global biotechnology company dedicated to revolutionizing cancer care. They are Headquartered in the US & Switzerland with a large footprint in the EU.
Outsourced internal GMP & GVP Audits
Outsourced internal GMP & GVP Audits Introduction Multinational biotech The French affiliate of a multinational Biotech company has its own QMS. Upon the QP responsibility, they conduct their internal audit with a 3-year plan (at the end of a 3 year cycle, they have audited all of their processes). Apotech consultants 2 External auditors Both…
GVP Audits Worldwide
GVP Audits Worldwide Introduction US Biotechnology Our client is a global Biotechnology company dedicated to genetics and molecular biology. They are Headquartered in the US, with offices in most major economies. Apotech auditors Our Auditors have 20+ years’ experience in the industry and have all conducted over 100 GVP audits. Types of Audits Affiliate Distributor/…